Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001662252-16-000168
Filing Date
2016-05-27
Accepted
2016-05-27 17:19:18
Documents
41
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-K micb10k.htm 10-K 538695
2 EX-31.1 ex31_1.htm EX-31.1 12927
3 EX-31.2 ex31_2.htm EX-31.2 12100
4 EX-32.1 ex32_1.htm EX-32.1 5048
5 GRAPHIC image_001.jpg GRAPHIC 18763
  Complete submission text file 0001662252-16-000168.txt   1691339

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE micb-20150930.xml EX-101.INS 156905
7 XBRL SCHEMA FILE micb-20150930.xsd EX-101.SCH 15678
8 XBRL CALCULATION FILE micb-20150930_cal.xml EX-101.CAL 21478
9 XBRL DEFINITION FILE micb-20150930_def.xml EX-101.DEF 46260
10 XBRL LABEL FILE micb-20150930_lab.xml EX-101.LAB 113576
11 XBRL PRESENTATION FILE micb-20150930_pre.xml EX-101.PRE 104818
Mailing Address 135 EAST 57TH STREET, 24TH FLOOR NEW YORK NY 10022
Business Address 135 EAST 57TH STREET, 24TH FLOOR NEW YORK NY 10022 646-406-6243
Microlin Bio, Inc (Filer) CIK: 0001547530 (see all company filings)

EIN.: 454507811 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-55425 | Film No.: 161683305
SIC: 6500 Real Estate